Jove
Visualize
Contact Us

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cancer Therapies02:49

Cancer Therapies

10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolation, Identification, and Growth Promotion Effects of Plant Growth-Promoting Rhizobacteria on Alfalfa.

Microorganisms·2026
Same author

Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistance.

Cell·2026
Same author

Detection of Pantoea ananatis in cerebrospinal fluid: a case report of central nervous system infection after craniotomy.

BMC infectious diseases·2026
Same author

Bayesian benchmark dose assessment of fluoride exposure and renal function impairment in adolescents.

International journal of environmental health research·2026
Same author

Safety and effectiveness of stereotactic radiosurgery for larger hemangioblastomas (>2cc): A multi-center retrospective study.

PloS one·2026
Same author

Integrating transcriptomic, physiological, and biochemical studies revealing the role of endogenous ABA and GA<sub>3</sub> in the germination of quinoa seed.

Frontiers in plant science·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 6, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.7K

Optimizing Radiotherapy with Immunotherapeutic Approaches.

Jonathan E Schoenhals1, Tijana Skrepnik2, Ugur Selek3,4

  • 1Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Advances in Experimental Medicine and Biology
|March 22, 2017
PubMed
Summary

Integrating immunotherapy with radiation requires careful consideration of preclinical findings and radiation techniques. Optimizing radiation therapy is crucial for successful combination treatments in patients.

Keywords:
CD8+ T-cellCTLA4Clinical trialImmunotherapyPD1RadiationSABRSBRTTGF-β

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.8K
Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.3K

Related Experiment Videos

Last Updated: Mar 6, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.7K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.8K
Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.3K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Immunotherapy

Background:

  • Successful integration of immunotherapy and radiation therapy into clinical practice necessitates addressing several key factors.
  • Preclinical findings regarding combination therapies, such as checkpoint inhibitors, tumor growth factor-beta (TGF-β) inhibitors, and natural killer (NK) cell therapy, require validation in preclinical models before patient application.
  • Traditional radiation therapy planning and delivery methods, standardized before advanced techniques, often use large treatment volumes that may not align with more conformal approaches.

Purpose of the Study:

  • To explore the challenges and considerations for combining immunotherapy with radiation therapy.
  • To provide insights into optimizing radiation therapy techniques for enhanced combination therapy efficacy.
  • To bridge the gap between preclinical research and clinical application of combined immunoradiotherapy.

Main Methods:

  • Review of existing preclinical data on immunotherapy and radiation combinations.
  • Analysis of radiation therapy planning and delivery techniques, including advanced methods.
  • Discussion of challenges posed by traditional radiation fractionation and field sizes in combination trials.

Main Results:

  • Preclinical models are essential for testing the efficacy and safety of combined immunotherapies (e.g., checkpoint inhibitors, TGF-β inhibitors, NK cell therapy) with radiation.
  • Standardized radiation protocols may not be optimal for combination therapy due to large treatment volumes and lack of adaptation to tumor dynamics.
  • Advanced radiation planning and delivery techniques offer potential solutions for optimizing treatment volumes and precision.

Conclusions:

  • Optimizing radiation therapy is critical for the successful clinical integration of immunotherapy.
  • Future combination trials must consider the interplay between radiation techniques and immunotherapeutic agents.
  • Further research into adaptive radiation strategies and conformal techniques is needed to maximize the benefits of combined immunoradiotherapy.